Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Romero

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
World Journal of Surgery|May 8, 2014
Elements for adequate informed consent in the surgical contextHernando Abaunza, Klaus Romero
International Review of Neurobiology|June 22, 2020
Placebo effect in subjects with cognitive impairmentKaori Ito, Klaus Romero
Pharmacoepidemiology and Drug Safety|April 22, 2009
Clarification to the www.qtdrugs.org updated listsKlaus Romero, Raymond L Woosley
Pacing and Clinical Electrophysiology : PACE|August 29, 2009
Time to replace Bazett's QT-correctionRaymond L Woosley, Klaus Romero
Nature Reviews. Cardiology|April 18, 2013
Assessing cardiovascular drug safety for clinical decision-makingRaymond L Woosley, Klaus Romero
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 30, 2016
Advancing tuberculosis drug regimen development through innovative quantitative translational pharmacology methods and approachesDebra Hanna, Klaus Romero, Marco Schito
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development ToolKlaus Romero, Robert Clay, Debra Hanna
Antimicrobial Agents and Chemotherapy|January 30, 2016
Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug DevelopmentEric Nuermberger, Christine Sizemore, Klaus Romero, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 11, 2013
Association of patient demographics on quality of life in a sample of adult patients with cardiac arrhythmiasDerek H Tang, Adrienne M Gilligan, Klaus Romero
Applied Health Economics and Health Policy|December 7, 2013
Economic burden and disparities in healthcare resource use among adult patients with cardiac arrhythmiaDerek H Tang, Adrienne M Gilligan, Klaus Romero
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
World Journal of Surgery|May 8, 2014
Elements for adequate informed consent in the surgical contextHernando Abaunza, Klaus Romero
International Review of Neurobiology|June 22, 2020
Placebo effect in subjects with cognitive impairmentKaori Ito, Klaus Romero
Pharmacoepidemiology and Drug Safety|April 22, 2009
Clarification to the www.qtdrugs.org updated listsKlaus Romero, Raymond L Woosley
Pacing and Clinical Electrophysiology : PACE|August 29, 2009
Time to replace Bazett's QT-correctionRaymond L Woosley, Klaus Romero
Nature Reviews. Cardiology|April 18, 2013
Assessing cardiovascular drug safety for clinical decision-makingRaymond L Woosley, Klaus Romero
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 30, 2016
Advancing tuberculosis drug regimen development through innovative quantitative translational pharmacology methods and approachesDebra Hanna, Klaus Romero, Marco Schito
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development ToolKlaus Romero, Robert Clay, Debra Hanna
Antimicrobial Agents and Chemotherapy|January 30, 2016
Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug DevelopmentEric Nuermberger, Christine Sizemore, Klaus Romero, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 11, 2013
Association of patient demographics on quality of life in a sample of adult patients with cardiac arrhythmiasDerek H Tang, Adrienne M Gilligan, Klaus Romero
Applied Health Economics and Health Policy|December 7, 2013
Economic burden and disparities in healthcare resource use among adult patients with cardiac arrhythmiaDerek H Tang, Adrienne M Gilligan, Klaus Romero
Pageof 9